Register Login
Register to leave comments
  • News bot Aug. 12, 2026, 12:18 p.m.

    📋 MADRIGAL PHARMACEUTICALS, INC. (MDGL) - Clinical Trial Update

    Filing Date: 2026-08-12

    Accepted: 2026-08-12 08:18:05

    Event Type: Clinical Trial Update

    Event Details:

    MADRIGAL PHARMACEUTICALS, INC. (MDGL) Announces Clinical Trial Update MADRIGAL PHARMACEUTICALS, INC. (MDGL) provided an update on its clinical development programs. Clinical Development Highlights:
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment, Regulatory Process, Regulatory Timeline
    • Collaboration: J&J

    🔬 Clinical Development Pipeline (MADRIGAL PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Placebo Other Phase PHASE2 MASH - Metabolic Dysfunction-Associated Steatohepatitis ClinicalTrials.gov
    Resmetirom Other Phase PHASE2 MASH - Metabolic Dysfunction-Associated Steatohepatitis ClinicalTrials.gov
    MGL-3196 (resmetirom) Other Phase PHASE2 Heterozygous Familial Hypercholesterolemia ClinicalTrials.gov
    Liver Biopsy Other Phase PHASE3 NASH - Nonalcoholic Steatohepatitis ClinicalTrials.gov
    MGL-3196 Other Phase PHASE3 NASH - Nonalcoholic Steatohepatitis ClinicalTrials.gov
    VIA-3196 Other Phase PHASE1 Drug Safety ClinicalTrials.gov
    Atorvastatin Other Phase PHASE1 Healthy ClinicalTrials.gov
    MGL-3196 Capsule Other Phase PHASE1 Healthy ClinicalTrials.gov
    MGL-3196 Tablet Other Phase PHASE1 Healthy ClinicalTrials.gov
    Pioglitazone 15mg Other Phase PHASE1 Healthy ClinicalTrials.gov
    Clopidogrel Other Phase PHASE1 Healthy ClinicalTrials.gov
    Rosuvastatin Other Phase PHASE1 Healthy ClinicalTrials.gov
    Simvastatin Other Phase PHASE1 Healthy ClinicalTrials.gov
    100 mg Resmetirom Tablet Other Phase PHASE1 Renal Impairment ClinicalTrials.gov
    Rezdiffra Other Preclinical MASH - Metabolic Dysfunction-Associated Steatohepatitis ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: MADRIGAL PHARMACEUTICALS, INC.
    • Ticker Symbol: MDGL

Search

News categories